G25520XG

Summary
GlyTouCan ID
G25520XG
IUPAC Condensed
Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-4)][Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc(b1-
Motifs
N-Glycan complex N-acetyllactosamine Type 2 LN
Subsumption Level
Fully-defined saccharide
Monoisotopic Mass
1989.73
GlyConnect structure
GlyGen
ChEBI
PubChem Compound
PubChem Substance
CarbBank
Organisms
Taxonomic Hierarchy
GlycoGene Database (GGDB)
Displaying 1 entry
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
FUT10 GDP-Fuc
G25520XG
R
G95617FJ
R
Displaying 1 entry
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
FUT10 GDP-Fuc
G25520XG
R
G95617FJ
R
KEGG BRITE Database
KEGG ID
GALAXY
Glucose Units
ODS
20.2
Amide
7.5
Degrading Enzymes
Displaying entries 1 - 5 of 8 in total
Enzyme Substrate Product
α-Fucosidase
G25520XG
G52934AK
α-Galactosidase
G61684ET
G25520XG
α-Sialidase
G94045IP
G25520XG
α-Sialidase
G14127XU
G25520XG
α-Sialidase
G91023GB
G25520XG
Sequence Descriptors
GlycoCT
RES
1b:b-dglc-HEX-1:5
2s:n-acetyl
3b:b-dglc-HEX-1:5
4s:n-acetyl
5b:b-dman-HEX-1:5
6b:a-dman-HEX-1:5
7b:b-dglc-HEX-1:5
8s:n-acetyl
9b:b-dgal-HEX-1:5
10b:b-dglc-HEX-1:5
11s:n-acetyl
12b:a-dman-HEX-1:5
13b:b-dglc-HEX-1:5
14s:n-acetyl
15b:b-dgal-HEX-1:5
16b:a-lgal-HEX-1:5|6:d
LIN
1:1d(2+1)2n
2:1o(4+1)3d
3:3d(2+1)4n
4:3o(4+1)5d
5:5o(3+1)6d
6:6o(2+1)7d
7:7d(2+1)8n
8:7o(4+1)9d
9:5o(4+1)10d
10:10d(2+1)11n
11:5o(6+1)12d
12:12o(2+1)13d
13:13d(2+1)14n
14:13o(4+1)15d
15:1o(6+1)16d
WURCS
WURCS=2.0/5,11,10/[a2122h-1b_1-5_2*NCC/3=O][a1122h-1b_1-5][a1122h-1a_1-5][a2112h-1b_1-5][a1221m-1a_1-5]/1-1-2-3-1-4-1-3-1-4-5/a4-b1_a6-k1_b4-c1_c3-d1_c4-g1_c6-h1_d2-e1_e4-f1_h2-i1_i4-j1
Literature
Displaying entries 11 - 20 of 44 in total
PubMed ID Title First Author Publication Date Source
21609021 Mass Spectrometric Determination of IgG Subclass-Specific Glycosylation Profiles in Siblings Discordant for Myositis Syndromes Perdivara I 2011 Jul 1
  • GlyGen
  • PubChem
20578731 Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia Stanta Johannes L 2010-09-03
  • GlyGen
14693911 Site-specific N-glycosylation of chicken serum IgG Suzuki Noriko 2004-03
  • GlyGen
15316280 Abnormal biantennary sugar chains are expressed in human chorionic gonadotropin produced in the choriocarcinoma cell line, JEG-3 Takamatsu S 2004
  • GlyGen
  • PubChem
12652077 Structural studies on IgG oligosaccharides of patients with primary Sjogren's syndrome Kuroda Y 2002 Jan
  • GlyGen
  • PubChem
11278492 Characterization of the glycosylation profiles of Alzheimer's beta -secretase protein Asp-2 expressed in a variety of cell lines Charlwood J 2001 May 18
  • GlyGen
  • PubChem
10704528 Characterization of the N-linked oligosaccharides of megalin (gp330) from rat kidney Morelle W 2000 Mar
  • GlyGen
  • PubChem
10929010 N-glycan patterns of human transferrin produced in Trichoplusia ni insect cells: effects of mammalian galactosyltransferase Ailor E 2000 Aug
  • GlyGen
  • PubChem
10029548 X-ray Crystallography and Mass Spectroscopy Reveal that the N-lobe of Human Transferrin Expressed inPichia pastorisIs Folded Correctly but Is Glycosylated on Serine-32, Bewley MC 1999 Feb 01
  • GlyGen
  • PubChem
10406848 Glycosylation of a CNS-specific extracellular matrix glycoprotein, tenascin-R, is dominated by O-linked sialylated glycans and 'brain-type' neutral N-glycans Zamze S 1999 Aug
  • GlyGen
  • PubChem

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.3.0

Last updated: August 4, 2025